Cargando…

Binding of the SARS-CoV-2 envelope E protein to human BRD4 is essential for infection

Emerging new variants of SARS-CoV-2 and inevitable acquired drug resistance call for the continued search of new pharmacological targets to fight the potentially fatal infection. Here, we describe the mechanisms by which the E protein of SARS-CoV-2 hijacks the human transcriptional regulator BRD4. W...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vann, Kendra R., Acharya, Arpan, Jang, Suk Min, Lachance, Catherine, Zandian, Mohamad, Holt, Tina A., Smith, Audrey L., Pandey, Kabita, Durden, Donald L., El-Gamal, Dalia, Côté, Jacques, Byrareddy, Siddappa N., Kutateladze, Tatiana G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212912/ https://www.ncbi.nlm.nih.gov/pubmed/35716662 http://dx.doi.org/10.1016/j.str.2022.05.020

Ejemplares similares

Characterization of multiple interactions between the envelope E protein of SARS-CoV-2 and human BRD4
por: Zandian, Mohamad, et al.
Publicado: (2022)

PI3K‐α/mTOR/BRD4 inhibitor alone or in combination with other anti‐virals blocks replication of SARS‐CoV‐2 and its variants of concern including Delta and Omicron
por: Acharya, Arpan, et al.
Publicado: (2022)

The BTK/PI3K/BRD4 axis inhibitor SRX3262 overcomes Ibrutinib resistance in mantle cell lymphoma
por: Pal, Dhananjaya, et al.
Publicado: (2021)

Combinatorial inhibition of BTK, PI3K-AKT and BRD4-MYC as a strategy for treatment of mantle cell lymphoma
por: Vann, Kendra R., et al.
Publicado: (2022)

Combining antiviral drugs with BET inhibitors is beneficial in combatting SARS‐CoV‐2 infection
por: Acharya, Arpan, et al.
Publicado: (2022)

Catching BETs by viruses
por: Zandian, Mohamad, et al.
Publicado: (2022)

Discovery and Evaluation of Entry Inhibitors for SARS-CoV-2 and Its Emerging Variants
por: Acharya, Arpan, et al.
Publicado: (2021)

Peptide Nanoarray Scaffold Vaccine for SARS-COV-2 and Its Variants of Concerns
por: Zagorski, Karen, et al.
Publicado: (2022)

Design of thienopyranone-based BET inhibitors that bind multiple synthetic lethality targets
por: Vann, Kendra R., et al.
Publicado: (2020)

Mental Health Issues During and After COVID-19 Vaccine Era
por: Pandey, Kabita, et al.
Publicado: (2021)

Modular nanoarray vaccine for SARS-CoV-2
por: Zagorski, Karen, et al.
Publicado: (2022)

Impact of Social Determinants of Health on the Emerging COVID-19 Pandemic in the United States
por: Singu, Sravani, et al.
Publicado: (2020)

Diminished Peripheral CD29hi Cytotoxic CD4+ T Cells Are Associated With Deleterious Effects During SIV Infection
por: Olwenyi, Omalla A., et al.
Publicado: (2021)

The 2022 outbreak and the pathobiology of the monkeypox virus
por: Kumar, Narendra, et al.
Publicado: (2022)

A Novel Triple-Action Inhibitor Targeting B-Cell Receptor Signaling and BRD4 Demonstrates Preclinical Activity in Chronic Lymphocytic Leukemia
por: Smith, Audrey L., et al.
Publicado: (2022)

Immunomodulatory LncRNA on antisense strand of ICAM-1 augments SARS-CoV-2 infection-associated airway mucoinflammatory phenotype
por: Devadoss, Dinesh, et al.
Publicado: (2022)

SARS-CoV-2 Infection Leads to Neurological Dysfunction
por: Acharya, Arpan, et al.
Publicado: (2020)

Chronic Morphine Administration Differentially Modulates Viral Reservoirs in a Simian Immunodeficiency Virus SIVmac251-Infected Rhesus Macaque Model
por: Acharya, Arpan, et al.
Publicado: (2021)

Inhibition of translation and immune responses by the virulence factor Nsp1 of SARS-CoV-2
por: Vann, Kendra R., et al.
Publicado: (2020)

Systems biology analyses reveal enhanced chronic morphine distortion of gut-brain interrelationships in simian human immunodeficiency virus infected rhesus macaques
por: Olwenyi, Omalla A., et al.
Publicado: (2022)

Biomarkers of Activation and Inflammation to Track Disparity in Chronological and Physiological Age of People Living With HIV on Combination Antiretroviral Therapy
por: Thurman, Michellie, et al.
Publicado: (2020)

Molecular Aspects of COVID-19 Differential Pathogenesis
por: Rothan, Hussin A., et al.
Publicado: (2020)

Defining the Innate Immune Responses for SARS-CoV-2-Human Macrophage Interactions
por: Abdelmoaty, Mai M., et al.
Publicado: (2021)

Therapeutic Potential of Cannabis: A Comprehensive Review of Current and Future Applications
por: Leinen, Zach J., et al.
Publicado: (2023)

A triple action CDK4/6-PI3K-BET inhibitor with augmented cancer cell cytotoxicity
por: Burgoyne, Adam M., et al.
Publicado: (2020)

Protocol for Biochemical Analysis and Structure Determination of the ZZ Domain of the E3 Ubiquitin Ligase HERC2
por: Liu, Jiuyang, et al.
Publicado: (2020)

Therapeutic implications of SARS-CoV-2 dysregulation of the gut-brain-lung axis
por: Johnson, Samuel D, et al.
Publicado: (2021)

Epigenetic countermarks in mitotic chromosome condensation
por: van Wely, Karel H. M., et al.
Publicado: (2017)

Safety and Immunological Evaluation of Interleukin-21 Plus Anti-α4β7 mAb Combination Therapy in Rhesus Macaques
por: Pino, Maria, et al.
Publicado: (2020)

Proteomic landscape of astrocytes and pericytes infected with HIV/SARS-CoV-2 mono/co-infection, impacting on neurological complications
por: Acharya, Arpan, et al.
Publicado: (2023)

ACE-2, TMPRSS2, and Neuropilin-1 Receptor Expression on Human Brain Astrocytes and Pericytes and SARS-CoV-2 Infection Kinetics
por: Malik, Johid Reza, et al.
Publicado: (2023)

Structural basis for binding diversity of acetyltransferase p300 to the nucleosome
por: Hatazawa, Suguru, et al.
Publicado: (2022)

NF-κB Duplications in the Promoter-Variant HIV-1C LTR Impact Inflammation Without Altering Viral Replication in the Context of Simian Human Immunodeficiency Viruses and Opioid-Exposure
por: Dave, Rajnish S., et al.
Publicado: (2020)

Immuno-epidemiology and pathophysiology of coronavirus disease 2019 (COVID-19)
por: Olwenyi, Omalla A., et al.
Publicado: (2020)

Immune landscape of female reproductive tract and HIV susceptibility
por: Byrareddy, Siddappa N.
Publicado: (2021)

COVID-19 and Cancer Comorbidity: Therapeutic Opportunities and Challenges
por: Pathania, Anup S., et al.
Publicado: (2021)

Retinoic Acid Improves the Recovery of Replication-Competent Virus from Latent SIV Infected Cells
por: Olwenyi, Omalla A., et al.
Publicado: (2020)

Rapamycin as a potential repurpose drug candidate for the treatment of COVID-19
por: Husain, Amjad, et al.
Publicado: (2020)

SARS-CoV2 induced respiratory distress: Can cannabinoids be added to anti-viral therapies to reduce lung inflammation?
por: Byrareddy, Siddappa N., et al.
Publicado: (2020)

Yaf9 subunit of the NuA4 and SWR1 complexes targets histone H3K27ac through its YEATS domain
por: Klein, Brianna J, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_28u6h45pksqlr6d5n8d15as81g